NEW YORK, April 27 (GenomeWeb News) - Jubilant Biosys, of Bangalore, India, said today that it has licensed its PathArt database of biochemical pathways to Genstruct for use in that company's drug discovery programs.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.
Technology Review points out that a new US presidential science advisor hasn't been selected.
Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.
President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.